Verana Health Expands Real World Data Bladder Cancer Database

Verana Health has expanded its real world data bladder cancer database to strengthen resources for genitourinary cancer research, announced in a press release. The update provides researchers with comprehensive longitudinal information on disease detection, treatment patterns, and patient outcomes.

The database, curated from electronic health records in the American Urological Association Quality Registry, transforms unstructured data into research ready datasets through AI and large language model techniques. It includes detailed variables such as T stage, tumor focality, tumor grade, and tumor response, covering both non muscle and muscle invasive bladder cancers.

This update follows Verana Health’s introduction of its prostate cancer dataset, described as the world’s largest curated real world dataset for that disease. The company’s recent merger with COTA expanded access to more than 30 academic medical centers and over 10 million oncology patients.

Verana Health’s expanded bladder cancer database coincides with the ASCO Annual Meeting in Chicago, where the company aims to highlight the role of real world data in advancing early detection and treatment research for genitourinary cancers.